Diseases & Disorders
(G50Z)
IRS Verified
DX Registered
990 on File
AMERICAN PARKINSON DISEASE ASSOC
Financial strength (30%)
67/100
Reliability (20%)
70/100
Effectiveness (25%)
83/100
Impact (25%)
75/100
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$18.8M
Total Revenue
$19.4M
Total Expenses
$27.1M
Net Assets
58
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.9%
Fundraising Efficiency
1227.0%
Operating Reserve
16.78x
Liability-to-Asset
10.1%
Revenue Diversification
98.6%
Executive Compensation
$1.2M
Compared with Peers
FY 2025
Compared with 77 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
74.9% | 85.3% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.3% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
15.9% | 0.8% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1227.0% | 350.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.8 mo | 9.7 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
10.1% | 20.6% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.6% | 92.8% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-19.3% | 8.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
5.9% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-3.0% | 2.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $18.8M | $19.4M | $27.1M | 74.9% | 58 |
| 2024 | $23.4M | $18.3M | $26.5M | 72.7% | 55 |
| 2023 | $12.9M | $15.4M | $20.6M | 75.8% | 46 |
| 2022 | $19.0M | $12.2M | $22.7M | 73.9% | 42 |
| 2021 | $14.6M | $11.9M | N/A | — | 42 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.